Caliper Life Sciences Acquisition of Xenogen Conference Call - Research and Markets Offers a Transcript of 'Caliper Life Sciences' Conference Call.DUBLIN, Ireland -- The Caliper Life Sciences (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CALP CALP Cognitive Academic Language Proficiency CALP Cristalleria Artistica La Piana (All the World, Crystalware) CALP Calsenilin-Like Protein CALP Centro de Astrofísica en la Palma (Canary Islands, Spain) ) Corporate Conference Call took place on 13-Feb-06 9:00am ET. CALP announced on 02/13/2006 its intent to acquire Xenogen Corporation. The combination is structured as an all-stock transaction, and CALP will issue 13.2m common shares plus 5.125m warrants in exchange for all of Xenogens outstanding equity, and using CALPs closing stock price as of 02/10/2006, the stock and warrant securities have a value of approx. $80m. Co. expects the transaction to be accretive on an EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) A metric used to show a company's profitability, but not its cash flow. EBITDA became popular in the 1980s to show the potential profitability of leveraged buyouts, but has become per share basis in 2006 and in 2007, and on an EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. basis in 2008. More information on this Conference Call can be obtained from Research and Markets at http://www.researchandmarkets.com/transcripts/80159 This document provides verbatim text of the conference call. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion